WE believe
portfolio
alpha
TEAM
IMPACT
Impact Report 2025
Impact Report 2024
Impact Report 2023
Impact Report 2022
Impact Report 2021
news & INSIGHTS
MIF Invests in Nectin Therapeutics to Evaluate Nectin’s Anti-PVR Lead Drug Candidate as a Treatment for Multiple Myeloma